ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01612039
Recruitment Status : Completed
First Posted : June 5, 2012
Last Update Posted : September 28, 2016
Sponsor:
Information provided by (Responsible Party):
Telsar Pharma Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : April 2014
  Certification/Extension First Submitted : April 20, 2016